Studieoverzicht

Study name: ELDAPT

Histology NSCLC
Tumor stage Stage I - III
Host / recruiting sites MUMC+
Key inclusion criteria

Inclusion criteria (let op korte versie, zie full protocol voor details)
Stage III NSCLC
Age ≥ 75 years
Any subtype of pathologically proven NSCLC, primary UICC Stage III disease;

  • No surgery or adjuvant chemotherapy for NSCLC in the last year;
  • No prior radiotherapy to the ipsilateral thorax or mediastinum;
  • No clinical superior vena cava syndrome;
  • No diagnosis of other cancer within the last 3-years (except in situ carcinoma’s and / or non-melanoma skin cancer);
Contact information